🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for IPF

Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis NCT05310669n/a1 site📍 Modena University of Modena and Reggio Emilia · Tests: Nasal pressure assessment Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies NCT01776398n/a1 site📍 New York Weill Medical College of Cornell University AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF NCT07194382Phase 249 sites📍 Camperdown📍 Kingswood📍 New Lambton Heights Avalyn Pharma Inc. · Tests: AP02, Placebo A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients NCT05139719Phase 21 site📍 Beijing Sunshine Lake Pharma Co., Ltd. · Tests: HEC585 dose A, HEC585 dose B, Placebo Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF) NCT06488638NA1 site📍 Southampton University Hospital Southampton NHS Foundation Trust · Tests: nitrate-rich beetroot juice (70ml with approx. 400 mg nitrate) twice a day for 3 days P4O2 ILD Extension NCT06644144n/a1 site📍 Amsterdam Amsterdam UMC, location VUmc · Tests: No Interventions Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases NCT06189820Phase 21 site📍 Brussels Erasme University Hospital · Tests: FAPI PET/CT A Phase Ia Clinical Trial of HW241045 NCT07448194Phase 11 site📍 Beijing Hubei Bio-Pharmaceutical Industrial Technological Institute… · Tests: HW241045, Placebo Validation of the C-mo System - Cough Monitoring NCT05989698NA8 sites📍 Alfena📍 Amadora📍 Aveiro Cough Monitoring Medical Solutions · Tests: C-mo System Retrospective Validation of AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CT NCT07761377n/a1 site📍 Taichung Taichung Veterans General Hospital · Tests: AccuPulmo CT Portal Western Sweden Systemic Sclerosis Project NCT07345052n/a1 site📍 Gothenburg Sahlgrenska University Hospital · Tests: No Intervention: Observational Cohort European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank NCT02852928n/a3 sites📍 Hanover📍 Ankara📍 Edinburgh Matthias Griese Advanced Imaging for Pulmonary Fibrosis NCT06532071Phase 21 site📍 Boston Peter Caravan · Tests: [68Ga]CBP8, Gadoterate Meglumine Dose-Escalation Study of Artesunate Patients With IPF NCT05988463Phase 11 site📍 Stanford Joseph C. Wu · Tests: Artesuante, Placebo capsules Effects of Pulmonary Diseases and Their Treatment on Cardiac Function NCT05042219n/a1 site📍 Aachen Ayham Daher · Tests: Cardiac MRI Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis NCT07192939Phase 21 site📍 Beijing Guangdong Hengrui Pharmaceutical Co., Ltd · Tests: HRS-9813 capsules, HRS-9813 capsules, HRS-9813 capsule mimetic Explanted Lung Tissues With Pulmonary Fibrosis NCT00515567n/a1 site📍 Chicago University of Chicago Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis NCT07230288Phase 257 sites📍 Birmingham📍 Dothan📍 Kissimmee AbbVie · Tests: ABBV-142, Placebo for ABBV-142 Better Tests- Improving Diagnostic Accuracy and Prognostication in Interstitial Lung Diseases NCT07615504n/a3 sites📍 Blackpool📍 Dundee📍 Perth University of Dundee A Prospective, Multi-Center Registry Study of Progressive Pulmonary Fibrosis (PPF) in China (PROFINA) NCT07683728n/a1 site📍 Beijing Zuojun Xu Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets NCT07671911Phase 322 sites📍 Newport Beach📍 Palm Springs📍 Redding Trevi Therapeutics · Tests: NAL ER, Placebo Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases NCT07464132Phase 1, Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Injection of 68Ga-NI-FAPI Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. NCT07466420NA1 site📍 Heraklion Katerina M. Antoniou · Tests: Quercetin (dietary supplement), Usual treatment A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. NCT07652658Phase 2195 sites📍 Birmingham📍 Phoenix📍 Phoenix AstraZeneca · Tests: Placebo for AZD8965, AZD8965 low dose, AZD8965 medium dose, AZD8965 high dose Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease NCT06751069NA4 sites📍 Scottsdale📍 Jacksonville📍 Minneapolis Mayo Clinic · Tests: Home-based Pulmonary Rehab Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis NCT07299695Phase 31 site📍 Pátrai Argyrios Tzouvelekis · Tests: Intravenous immunoglobulin (IVIG), Usual treatment A Study of the Natural Progression of Interstitial Lung Disease (ILD) NCT00470327n/a1 site📍 Chicago University of Chicago Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole NCT04965298Phase 357 sites📍 Norwich📍 Aberdeen📍 Antrim Norfolk and Norwich University Hospitals NHS Foundation Tru… · Tests: Lansoprazole, Matched placebo Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF) NCT07284602Phase 318 sites📍 Palm Spring📍 Redding📍 Hialeah PureTech · Tests: Deupirfenidone, Pirfenidone (PFD) The Role of Laryngopharyngeal Reflux in IPF NCT03418350n/a1 site📍 Denver National Jewish Health
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy